{"filing":{"accession_number":"0001213900-26-060075","cik":"0001711786","ticker":"HOTH","company_name":"Hoth Therapeutics, Inc.","form":"8-K","filing_date":"2026-05-21","report_date":null,"primary_document":"ea0291837-8k_hoth.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1711786/000121390026060075/ea0291837-8k_hoth.htm"},"events":[{"id":9456,"run_id":8292,"accession_number":"0001213900-26-060075","anchor_item_number":"1.01","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"summary":"Hoth Therapeutics entered into two exclusive license agreements with Virginia Commonwealth University on May 15, 2026, granting its subsidiary Rocket One exclusive and non-exclusive rights to patents and technical information in the data center and AI field, with royalty payments, minimum annual payments, and sublicensing rights.","company_name":"Hoth Therapeutics, Inc.","ticker":"HOTH","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1103,"accession_number":"0001213900-26-060075","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Hoth Therapeutics entered into two exclusive license agreements with Virginia Commonwealth University on May 15, 2026, granting its subsidiary Rocket One exclusive and non-exclusive rights to patents and technical information in the data center and AI field. The agreements include royalty payments, minimum annual payments, and sublicensing rights, constituting a material definitive agreement that would affect investor assessment of the company's intellectual property portfolio and commercial opportunities.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:31.250892+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":9457,"run_id":8292,"accession_number":"0001213900-26-060075","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"summary":"Hoth Therapeutics announced a material name change to Rocket One, Inc. and a fundamental strategic pivot from therapeutics to artificial intelligence infrastructure, semiconductors, and ultra-low-power AI computing.","company_name":"Hoth Therapeutics, Inc.","ticker":"HOTH","filing_date":"2026-05-21","form":"8-K","submitted_at":null,"items":[{"id":1104,"accession_number":"0001213900-26-060075","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The company announced a material name change from \"Hoth Therapeutics, Inc.\" to \"Rocket One, Inc.\" coupled with a stated intent to restructure and pivot its business focus from therapeutics to artificial intelligence infrastructure, semiconductors, and ultra-low-power AI computing. This represents a fundamental strategic shift that would affect a reasonable investor's assessment of the registrant's business direction and risk profile, though the disclosure does not fit neatly into more specific event categories such as M\u0026A activity, going concern, or material impairment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:31.250892+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":1103,"accession_number":"0001213900-26-060075","item_number":"1.01","item_title":"Entry into a Material Definitive","event_type":"ma_activity","event_domain":"operational","is_material":true,"confidence":0.92,"reasoning":"Hoth Therapeutics entered into two exclusive license agreements with Virginia Commonwealth University on May 15, 2026, granting its subsidiary Rocket One exclusive and non-exclusive rights to patents and technical information in the data center and AI field. The agreements include royalty payments, minimum annual payments, and sublicensing rights, constituting a material definitive agreement that would affect investor assessment of the company's intellectual property portfolio and commercial opportunities.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:31.250892+00:00","company_name":"Hoth Therapeutics, Inc.","ticker":"HOTH","filing_date":"2026-05-21"},{"id":1104,"accession_number":"0001213900-26-060075","item_number":"8.01","item_title":"Other Events.","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.75,"reasoning":"The company announced a material name change from \"Hoth Therapeutics, Inc.\" to \"Rocket One, Inc.\" coupled with a stated intent to restructure and pivot its business focus from therapeutics to artificial intelligence infrastructure, semiconductors, and ultra-low-power AI computing. This represents a fundamental strategic shift that would affect a reasonable investor's assessment of the registrant's business direction and risk profile, though the disclosure does not fit neatly into more specific event categories such as M\u0026A activity, going concern, or material impairment.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-05-22T02:57:31.250892+00:00","company_name":"Hoth Therapeutics, Inc.","ticker":"HOTH","filing_date":"2026-05-21"}]}